You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Akt Inhibitors to Treat Ewing's Sarcoma
SBC: Acenta Discovery, Inc. Topic: N/ADESCRIPTION (provided by applicant): Novel drugs that improve overall survival with decreased morbidity are critical in the war on cancer. Acenta Discovery Inc. has partnered with the Toretsky Lab of the Lombardi Cancer Center to create and preclinically evaluate novel inhibitors of the protein Akt. An Akt inhibitor would have tremendous value in improving the lives of patients with many types ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Caspase Inhibitor for Neuroprotection
SBC: Acenta Discovery, Inc. Topic: N/ADESCRIPTION (provided by applicant): An important role for apoptosis has been established in various pathological processes, particularly in nervous tissues. Apoptosis essentially contributes to neuronal loss during normal development, after acute neuronal injury, and in chronic degenerative conditions such as Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly impacts quality of life while generating tremendous ongoing health care costs and losses to productivity. Recent scientific and clinical findings have ...
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
TRACHEAL GAS INSUFFLATION- PATIENT INTERFACE SYSTEM
SBC: ALVEOLI MEDICAL, LLC Topic: N/ADESCRIPTION (provided by applicant): The benefits of Tracheal Gas Insufflation (TGI) as an adjunct to mechanical ventilation are well known. 1 TGI reduces dead space and CO2 rebreathing in mechanically ventilated patients, thereby reducing PaCO2 with no c
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Low-temperature Electrocatalytic Oxidation of VOCs
SBC: AMSEN TECHNOLOGIES LLC Topic: N/ADESCRIPTION (provided by applicant): In this program AMSEN Technologies aims to develop a novel electrocatalytic air filter for low-temperature oxidative destruction of VOCs. The proposed idea is an innovative combination of electrochemically enhanced ads
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Transgenic indicator cells for influenza virus
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by applicant): Influenza virus causes a pandemic disease of the respiratory tract that results in significant human morbidity and mortality. Diagnosis of influenza virus infection during the winter months makes up a large component
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Molecular tools for Bunyavirus antiviral screening
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by investigator): Several viruses in the family Bunyaviridae are significant human pathogens and potential agents of bioterrorism. Vaccines against some of these viruses do exist, but with the exception of ribavarin, there are no broad-spectrum antiviral compounds capable of inhibiting replication of more than one member of the family. Using LaCrosse virus (LAC) as a prototyp ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Replicon-based screening for inhibitors of alphaviruses
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by applicant): The goal in this study is to develop a cell-based assay to screen compounds for antiviral activity against certain members of the Togavirus family. We are particularly targeting the more pathogenic encephalitis-causing
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Production of human CD39 as an antithrombotic agent
SBC: APT THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Production of a human apyrase protein as an antithrombotic agent is proposed. Thrombotic vascular occlusion due to abnormal platelet aggregation can lead to many diseases, including ischemic stroke, myocardial infarcti
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Enhanced digital imaging for improved vascular access
SBC: Arete Associates Topic: N/ADESCRIPTION (provided by applicant): Phase I Arete Associates and Infrared Imaging Systems Inc. propose an innovative technology development that will safely and efficiently improve vascular access for cannulation by providing real-time high re
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health